在COPD中,CH25H/25-HC通过AMPK/STAT6通路依赖的M2巨细胞极化促进肺纤维化
Ying Li1, Guangzhi Xiao1, Xianghui Fu1
1Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Immunobiology
|May 1, 2025
概括
CH25H/25-胆固醇 (25-HC) 在慢性阻塞性肺病 (COPD) 中通过激活AMPK/STAT6依赖的M2巨细胞两极分化来促进肺纤维化. 向CH25H为COPD相关纤维化提供了一个潜在的治疗策略.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 肺纤维化是慢性阻塞性肺病 (COPD) 的重要并发症.
- 连接COPD和肺纤维化的精确分子机制尚未完全理解.
- CH25H及其产物25-胆固醇 (25-HC) 已成为纤维性疾病的潜在参与者.
研究的目的:
- 研究CH25H/25-HC在促进COPD肺纤维化中的作用.
- 为了确定CH25H/25-HC是否调节COPD中的AMPK/STAT6依赖的M2巨细胞极化.
- 探索CH25H作为COPD相关的肺纤维化治疗的潜在治疗标.
主要方法:
- 分析了GEO数据集和香烟烟雾引起的COPD小鼠模型.
- 使用腺相关病毒 (AAV) 输送的shRNA.CH25H沉默.
- 通过流动细胞计,qPCR和西部斑点检测评估组织病理学,肺功能,巨分极 (M1/M2) 和AMPK/STAT6通路活性.
主要成果:
- 在COPD肺组织和巨细胞中观察到显著增加的CH25H表达.
- 在COPD小鼠中,CH25H Knockdown改善了肺损伤,呼吸道重塑和纤维化.
- 抑制CH25H抑制了M2巨细胞极化,并减少了AMPK/STAT6通路的激活,AMPKα激活剂GSK621.6反转了保护作用.
结论:
- CH25H/25-HC通过AMPK/STAT6通路促进M2巨细胞极化,加剧COPD相关的肺纤维化.
- 向CH25H为COPD相关纤维化提供了一个有前途的新疗法策略.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Pathogenesis and Clinical Features
170
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
170
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K


